LIVE ESMO GI 2026 Live — top KOL voices, trial buzz & conference slides from Munich View Live Coverage →
KOL Pulse Insights Blog

Oncology KOL Intelligence, decoded.

Key opinion leader trends, clinical-trial commentary, conference recaps, and AI-native intelligence on the physicians shaping oncology practice — straight from the social conversation.

3Articles
WeeklyNew insights
500+Verified oncologists tracked
0 articles · All topics
Is Ivonescimab Too Good To Be True? Highlights of Dr. John Heymach's Uromigos Podcast
Mar 26, 2025 5:34:39 PM Brian Shields

Is Ivonescimab Too Good To Be True? Highlights of Dr. John Heymach's Uromigos Podcast

Dr. John Heymach provided the Uromigos with a review on the HARMONi-2 trial of ivonescimab in NSCLC

lung cancerivonescimaburomigos
AI Generated KOL Network Mapping - ivonescimab discussion
Feb 12, 2025 12:00:11 PM Brian Shields

AI Generated KOL Network Mapping - ivonescimab discussion

Key Opinion Leader Network Mapping through KOL Pulse AI generated social network visualization of KOL discussions of HARMONi-A from #ASCO24

asco24ivonescimabHARMONi-A
Using AI to Understand ivonescimab - KOL Pulse AI Demo
Feb 11, 2025 8:19:45 AM Brian Shields

Using AI to Understand ivonescimab - KOL Pulse AI Demo

Akeso biopharma published a preprint of the mechanism of action of ivonescimab. Can the KOL Pulse AI provide context to KOL questions about HARMONi-A?

KOLasco24Key Opinion Leader

Track the KOLs shaping oncology

KOL Pulse turns the oncology social conversation into AI-native intelligence. See it in action.

Book a Demo Back to Homepage